| dc.creator | Velloso, L A | |
| dc.creator | Folli, F | |
| dc.creator | Sun, X J | |
| dc.creator | White, M F | |
| dc.creator | Saad, M J | |
| dc.creator | Kahn, C R | |
| dc.date | 1996-Oct | |
| dc.date | 2015-11-27T12:18:47Z | |
| dc.date | 2015-11-27T12:18:47Z | |
| dc.date.accessioned | 2018-03-29T00:51:55Z | |
| dc.date.available | 2018-03-29T00:51:55Z | |
| dc.identifier | Proceedings Of The National Academy Of Sciences Of The United States Of America. v. 93, n. 22, p. 12490-5, 1996-Oct. | |
| dc.identifier | 0027-8424 | |
| dc.identifier | | |
| dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/8901609 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/193948 | |
| dc.identifier | 8901609 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1294181 | |
| dc.description | Angiotensin II (AII), acting via its G-protein linked receptor, is an important regulator of cardiac, vascular, and renal function. Following injection of AII into rats, we find that there is also a rapid tyrosine phosphorylation of the major insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) in the heart. This phenomenon appears to involve JAK2 tyrosine kinase, which associates with the AT1 receptor and IRS-1/IRS-2 after AII stimulation. AII-induced phosphorylation leads to binding of phosphatidylinositol 3-kinase (PI 3-kinase) to IRS-1 and IRS-2; however, in contrast to other ligands, AII injection results in an acute inhibition of both basal and insulin-stimulated PI 3-kinase activity. The latter occurs without any reduction in insulin receptor or IRS phosphorylation or in the interaction of the p85 and p110 subunits of PI 3-kinase with each other or with IRS-1/IRS-2. These effects of AII are inhibited by AT1 receptor antagonists. Thus, there is direct cross-talk between insulin and AII signaling pathways at the level of both tyrosine phosphorylation and PI 3-kinase activation. These interactions may play an important role in the association of insulin resistance, hypertension, and cardiovascular disease. | |
| dc.description | 93 | |
| dc.description | 12490-5 | |
| dc.language | eng | |
| dc.relation | Proceedings Of The National Academy Of Sciences Of The United States Of America | |
| dc.relation | Proc. Natl. Acad. Sci. U.S.A. | |
| dc.rights | aberto | |
| dc.rights | | |
| dc.source | PubMed | |
| dc.subject | Angiotensin Ii | |
| dc.subject | Animals | |
| dc.subject | Electrophoresis, Polyacrylamide Gel | |
| dc.subject | Insulin | |
| dc.subject | Insulin Receptor Substrate Proteins | |
| dc.subject | Intracellular Signaling Peptides And Proteins | |
| dc.subject | Janus Kinase 1 | |
| dc.subject | Janus Kinase 2 | |
| dc.subject | Janus Kinase 3 | |
| dc.subject | Male | |
| dc.subject | Phosphatidylinositol 3-kinases | |
| dc.subject | Phosphoproteins | |
| dc.subject | Phosphorylation | |
| dc.subject | Phosphotransferases (alcohol Group Acceptor) | |
| dc.subject | Protein-tyrosine Kinases | |
| dc.subject | Proto-oncogene Proteins | |
| dc.subject | Rats | |
| dc.subject | Rats, Wistar | |
| dc.subject | Signal Transduction | |
| dc.subject | Tyrosine | |
| dc.title | Cross-talk Between The Insulin And Angiotensin Signaling Systems. | |
| dc.type | Artículos de revistas | |